Speaker illustration

Assistant Professor Biljana Parapid

Faculty of Medicine, University of Belgrade, Belgrade (Serbia)

Member of:

EAPCI
Heart Failure Association

Dr Parapid is Assistant Professor of Medicine at Belgrade University School of Medicine (BUSM) & Honorary Proctor W.Harvey Teaching Professor at Georgetown University School of Medicine (GUSM). She got part of her Medicine residency training at GUSM (2004) & her Fellowship (2011) from Paris VII Diderot University’s Bichat hospital enabled her to help re-launch heart transplant program in Serbia in 2013. Her research interests include coronary anatomy (in particular myocardial bridges), atherosclerosis disparities & metabolic syndrome. Dr Parapid’s passion for women’s health & her activities with ACC – as WIC section Leadership Council member & founding Chair of WIC Intl WG – helped her make her med school dream come true: “Dr Nanette Kass Wenger” Women’s Heart Center’s opening its doors at BUSM in 2020 as first in the region, with AHA support as she’s bringing Go Red for Women to Serbia too. EuroIntervention SoMe awardee 2019, Dr Parapid can be followed @biljana_parapid

Metabolic syndrome and mortality prediction in the seven countries' study: single or multifactorial

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Session: Risk Factors and Prevention ePosters

Thumbnail

Sex-based differences in cardioprotective role of SGLT-2 inhibitors in patients with type 2 diabetes mellitus

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Diabetes

Thumbnail

Family history impact in the setting of the metabolic syndrome: the 40 year follow-up results of the seven countries study

Event: ESC CONGRESS 2016

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Dealing with metabolic disorders

Thumbnail

Practical anthropometric measurements in the setting of an existing metabolic syndrome: the 40 year follow-up results of the Seven Countries Study

Event: ESC CONGRESS 2016

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Fighting againts diabetes epidemic

Thumbnail

This platform is supported by

logo Novo Nordisk